| DAA2006 |
miR-130a expression decreases with age |
Molecular |
blood, immune system |
Human |
MIR130A |
— |
|
| DAA2007 |
miR-155 expression decreases with age |
Molecular |
blood, immune system |
Human |
MIR155 |
— |
|
| DAA2008 |
miR-24 expression decreases with age |
Molecular |
blood, immune system |
Human |
MIR24-1 |
— |
|
| DAA2009 |
miR-24 expression decreases with age |
Molecular |
blood, immune system |
Human |
MIR24-2 |
— |
|
| DAA2010 |
miR-221 expression decreases with age |
Molecular |
blood, immune system |
Human |
MIR221 |
— |
|
| DAA2011 |
miR-496 expression decreases with age |
Molecular |
blood, immune system |
Human |
MIR496 |
— |
|
| DAA2012 |
miR-1538 expression decreases with age |
Molecular |
blood, immune system |
Human |
MIR1538 |
— |
|
| DAA2013 |
Number and differentiation potential of adipose tissue-derived stem cells declines with age |
Physiological |
mesenchymal stem cell |
Human |
— |
— |
|
| DAA2014 |
Microsatellite instability in hematopoietic stem cells and progenitor cells |
Physiological |
hematopoietic stem cells |
Human |
MLH1 |
— |
|
| DAA2015 |
Regulation of the acid-base equilibrium of the blood unchanged |
Physiological |
blood |
Human |
— |
— |
|
| DAA2017 |
Blood sugar changes |
Physiological |
plasma |
Human |
— |
— |
|
| DAA2018 |
Blood volume per unit of body weight unchanged |
Physiological |
blood |
Human |
— |
— |
|
| DAA2022 |
Prolactin decreases in females |
Physiological |
plasma |
Human |
— |
— |
|
| DAA2027 |
DNA damage acummulates in hematopoietic stem and progenitor cells |
Physiological |
hematopoietic stem cells |
Human |
— |
— |
|
| DAA2034 |
Expression of WRN decreases |
Molecular |
blood, immune system |
Human |
WRN |
52.0% Decrease Gene Expression Level |
|
| DAA2035 |
Alterations in frequency, developmental potential and gene expression profile in hematopoietic stem cells |
Physiological |
hematopoietic stem cells |
Human |
— |
— |
|
| DAA2038 |
Concentration of cell free DNA increases |
Molecular |
plasma |
Human |
— |
— |
|
| DAA2047 |
creatinine levels increase |
Molecular |
plasma |
Human |
— |
— |
|
| DAA2055 |
Circulating miR-21 expression increases |
Molecular |
blood |
Human |
— |
— |
|
| DAA2058 |
Mosaic abnormalities increase |
Physiological |
blood, oral cavity |
Human |
— |
— |
|
| DAA2432 |
sperm associated antigen 7 decreases with age |
Molecular |
mesenchymal stem cell |
Human |
SPAG7 |
26.2% Decrease DNA Methylation |
|
| DAA2433 |
cyclin-dependent kinase inhibitor 2B isoform 2 decreases with age |
Molecular |
mesenchymal stem cell |
Human |
CDKN2B |
16.7% Decrease DNA Methylation |
|
| DAA2434 |
nerve growth factor; beta polypeptide precursor decreases with age |
Molecular |
mesenchymal stem cell |
Human |
NGF |
22.5% Decrease DNA Methylation |
|
| DAA2435 |
zinc finger protein 549 increases with age |
Molecular |
mesenchymal stem cell |
Human |
ZNF549 |
19.3% Increase DNA Methylation |
|
| DAA2436 |
selenium binding protein 1 decreases with age |
Molecular |
mesenchymal stem cell |
Human |
SELENBP1 |
20.8% Decrease DNA Methylation |
|